Ironwood Pharmaceuticals (IRWD) Short Interest Ratio & Short Volume → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free IRWD Stock Alerts $6.48 -0.16 (-2.41%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Ironwood Pharmaceuticals Short Interest DataCurrent Short Volume20,080,000 sharesPrevious Short Volume21,160,000 sharesChange Vs. Previous Month-5.10%Dollar Volume Sold Short$155.62 millionShort Interest Ratio / Days to Cover4.5Last Record DateApril 30, 2024Outstanding Shares156,529,000 sharesFloat Size153,960,000 sharesShort Percent of Float13.04%Today's Trading Volume1,468,400 sharesAverage Trading Volume4,128,058 sharesToday's Volume Vs. Average36% Short Selling Ironwood Pharmaceuticals ? Sign up to receive the latest short interest report for Ironwood Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIRWD Short Interest Over TimeIRWD Days to Cover Over TimeIRWD Percentage of Float Shorted Over Time Ad Stansberry Research41 banks launch ‘crypto dollar’Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here).Here's how you capitalize (including #1 crypto to play it). Ironwood Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202420,080,000 shares $155.62 million -5.1%13.0%4.5 $7.75 4/15/202421,160,000 shares $164.84 million -3.6%14.0%4.6 $7.79 3/31/202421,950,000 shares $191.18 million +16.9%14.5%4.6 $8.71 3/15/202418,770,000 shares $169.31 million +21.0%12.4%4 $9.02 2/29/202415,510,000 shares $146.26 million -0.6%10.2%3.8 $9.43 2/15/202415,600,000 shares $233.84 million +7.9%10.3%5.5 $14.99 Get the Latest News and Ratings for IRWD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ironwood Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/202414,460,000 shares $205.19 million -10.1%9.5%5.4 $14.19 1/15/202416,080,000 shares $195.37 million +2.0%12.8%6.5 $12.15 12/31/202315,760,000 shares $180.29 million -7.3%10.3%7.4 $11.44 12/15/202317,000,000 shares $189.21 million +2.3%11.2%7.8 $11.13 11/30/202316,620,000 shares $164.54 million -3.1%10.9%6.8 $9.90 11/15/202317,150,000 shares $167.38 million -1.4%11.3%6.9 $9.76 10/31/202317,390,000 shares $155.99 million -0.9%11.4%6.7 $8.97 10/15/202317,540,000 shares $164.00 million -0.6%11.5%6.8 $9.35 9/30/202317,640,000 shares $169.87 million +20.3%11.6%7.1 $9.63 9/15/202314,660,000 shares $122.26 million -5.4%9.6%6.1 $8.34 8/31/202315,500,000 shares $136.40 million +3.9%10.2%7.2 $8.80 8/15/202314,920,000 shares $147.11 million -1.8%9.8%7.1 $9.86 7/31/202315,190,000 shares $168.46 million -6.5%10.0%7.3 $11.09 7/15/202316,250,000 shares $168.35 million +13.5%10.7%7.9 $10.36 6/30/202314,320,000 shares $152.36 million -17.9%9.5%6.4 $10.64 6/15/202317,450,000 shares $192.47 million -1.0%11.5%7 $11.03 5/31/202317,620,000 shares $191.71 million +6.4%11.6%7.3 $10.88 5/15/202316,560,000 shares $174.38 million -3.3%10.9%6.7 $10.53 4/30/202317,130,000 shares $178.32 million -14.9%11.3%7.3 $10.41 4/15/202320,130,000 shares $221.23 million +14.1%13.4%8.8 $10.99 3/31/202317,640,000 shares $185.57 million +8.0%11.8%7.6 $10.52 3/15/202316,330,000 shares $170.32 million +1.0%10.9%8.4 $10.43 2/28/202316,170,000 shares $182.24 million +1.4%10.7%8.3 $11.27 2/15/202315,950,000 shares $178.64 million -0.1%10.6%8.4 $11.20 1/31/202315,970,000 shares $183.97 million +0.1%10.7%8.5 $11.52 1/15/202315,950,000 shares $184.86 million -2.6%10.7%8.7 $11.59 12/30/202216,370,000 shares $202.82 million -3.4%10.9%8.8 $12.39 12/15/202216,950,000 shares $204.25 million +2.8%11.4%8.9 $12.05 11/30/202216,490,000 shares $199.69 million -12.3%11.1%8.2 $12.11 11/15/202218,810,000 shares $214.62 million +9.7%12.6%8.9 $11.41 10/31/202217,150,000 shares $187.62 million -1.6%11.4%8.1 $10.94 10/15/202217,420,000 shares $175.77 million +0.2%11.7%7.5 $10.09 9/30/202217,390,000 shares $180.16 million -3.3%11.7%7.5 $10.36 9/15/202217,980,000 shares $196.16 million -1.1%12.1%7.6 $10.91Next President (Not Trump. Not Biden.) (Ad)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________. IRWD Short Interest - Frequently Asked Questions What is Ironwood Pharmaceuticals' current short interest? Short interest is the volume of Ironwood Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 20,080,000 shares of IRWD short. 13.04% of Ironwood Pharmaceuticals' shares are currently sold short. Learn More on Ironwood Pharmaceuticals' current short interest. What is a good short interest ratio for Ironwood Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IRWD shares currently have a short interest ratio of 4.0. Learn More on Ironwood Pharmaceuticals's short interest ratio. Which institutional investors are shorting Ironwood Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ironwood Pharmaceuticals: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Ironwood Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.04% of Ironwood Pharmaceuticals' floating shares are currently sold short. Is Ironwood Pharmaceuticals' short interest increasing or decreasing? Ironwood Pharmaceuticals saw a drop in short interest in April. As of April 30th, there was short interest totaling 20,080,000 shares, a drop of 5.1% from the previous total of 21,160,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Ironwood Pharmaceuticals' float size? Ironwood Pharmaceuticals currently has issued a total of 156,529,000 shares. Some of Ironwood Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ironwood Pharmaceuticals currently has a public float of 153,960,000 shares. How does Ironwood Pharmaceuticals' short interest compare to its competitors? 13.04% of Ironwood Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Ironwood Pharmaceuticals: Innoviva, Inc. (18.39%), OPKO Health, Inc. (26.42%), MannKind Co. (13.13%), Cryoport, Inc. (8.74%), Dynavax Technologies Co. (14.99%), IGM Biosciences, Inc. (29.87%), Ligand Pharmaceuticals Incorporated (4.42%), Kura Oncology, Inc. (13.59%), Lexicon Pharmaceuticals, Inc. (9.52%), Verastem, Inc. (3.49%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Ironwood Pharmaceuticals stock? Short selling IRWD is an investing strategy that aims to generate trading profit from Ironwood Pharmaceuticals as its price is falling. IRWD shares are trading down $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ironwood Pharmaceuticals? A short squeeze for Ironwood Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IRWD, which in turn drives the price of the stock up even further. How often is Ironwood Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IRWD, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Innoviva Short Interest OPKO Health Short Interest MannKind Short Interest Cryoport Short Interest Dynavax Technologies Short Interest IGM Biosciences Short Interest Ligand Pharmaceuticals Short Interest Kura Oncology Short Interest Lexicon Pharmaceuticals Short Interest Verastem Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IRWD) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders